ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.650,47
-0,17%
S&P 500
5.316,47
0,18%
Dow Jones
39.468,85
-0,51%
Euro vs US Dollar
1,08332
0,08%
Bitcoin
67.934,18
-1,69%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Avid Bioservices Inc (CDMOP)

  7. Avid Bioservices Inc (CDMOP) News

CDMOP

Avid Bioservices (CDMOP)

Avid Bioservices Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CDMOP
DatumZeitQuelleÜberschriftSymbolFirma
23/05/202414h05GlobeNewswire Inc.Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability PerformanceNASDAQ:CDMOPAvid Bioservices Inc
07/05/202422h05GlobeNewswire Inc.Avid Bioservices to Participate at Upcoming Investor ConferencesNASDAQ:CDMOPAvid Bioservices Inc
24/04/202423h25GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024NASDAQ:CDMOPAvid Bioservices Inc
20/03/202412h00GlobeNewswire Inc.Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-QNASDAQ:CDMOPAvid Bioservices Inc
07/03/202405h58GlobeNewswire Inc.Avid Bioservices Announces Pricing of Private Placement of Convertible NotesNASDAQ:CDMOPAvid Bioservices Inc
06/03/202422h32GlobeNewswire Inc.Avid Bioservices Announces Proposed Private Placement of Convertible NotesNASDAQ:CDMOPAvid Bioservices Inc
06/03/202422h31GlobeNewswire Inc.Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024NASDAQ:CDMOPAvid Bioservices Inc
07/12/202322h05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023NASDAQ:CDMOPAvid Bioservices Inc
30/11/202322h05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023NASDAQ:CDMOPAvid Bioservices Inc
08/11/202314h05GlobeNewswire Inc.Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) ProgramsNASDAQ:CDMOPAvid Bioservices Inc
17/10/202314h05GlobeNewswire Inc.Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing FacilityNASDAQ:CDMOPAvid Bioservices Inc
26/09/202322h05GlobeNewswire Inc.Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO ConferenceNASDAQ:CDMOPAvid Bioservices Inc
07/09/202322h05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023NASDAQ:CDMOPAvid Bioservices Inc
31/08/202322h05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023NASDAQ:CDMOPAvid Bioservices Inc
21/06/202323h01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CDMOPAvid Bioservices Inc
21/06/202322h47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDMOPAvid Bioservices Inc
21/06/202322h07GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023NASDAQ:CDMOPAvid Bioservices Inc
14/06/202322h05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023NASDAQ:CDMOPAvid Bioservices Inc
09/06/202301h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
10/05/202322h05GlobeNewswire Inc.Avid Bioservices to Participate in RBC Capital Markets Global Healthcare ConferenceNASDAQ:CDMOPAvid Bioservices Inc
10/05/202301h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
06/05/202301h36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CDMOPAvid Bioservices Inc
06/05/202301h36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CDMOPAvid Bioservices Inc
03/05/202301h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
03/05/202301h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
15/04/202301h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
13/04/202301h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
12/04/202301h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
12/04/202301h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
08/04/202301h36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
 Showing the most relevant articles for your search:NASDAQ:CDMOP

Kürzlich von Ihnen besucht

TG
QH9
ADTRAN
BIT
P213U2
NLBNPIT213U2 20240515 19...
COIN
XPRTETH
Persistence
BOV
VIVT3
TELEF BRASIL ON
EU
ESGCN
Euronext Eurozone ESG Le...
BIT
S27875
Societe Generale Effekten
BIT
UB7HN8
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten